Clinical trial
The Effects of Rosuvastatin on Physiological Adaptation and Safety During Regular Long-Distance Running Training: A Randomized Controlled Trial
NCT07401017 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Rosuvastatin on Physiological Adaptation and Safety During Regular Long-Distance Running Training: A Randomized Controlled Trial
- Lead sponsor
- Taipei Medical University WanFang Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 1, 2026
- Completion date
- October 31, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dyslipidemia, endurance training, long-distance running, statin-associated muscle symptoms